Evidence map›Paper›PMID 37305682›Full record

ReviewFrontiers in cell and developmental biology2023

Merits and challenges of iPSC-derived organoids for clinical applications.

Ziran Xu, Jiaxu Yang, Xianyi Xin, Chengrun Liu, Lisha Li, Xianglin Mei, Meiying Li

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. A Translational Roadmap for Neurological Nonsense Mutation Disorders.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ziran XuThe Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
Jiaxu YangDepartment of Neonatology, The First Hospital of Jilin University, Changchun, Jilin, China.
Xianyi XinDepartment of Pediatric Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
Chengrun LiuThe Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
Lisha LiThe Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
Xianglin MeiDepartment of pathology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Meiying LiThe Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) have entered an unprecedented state of development since they were first generated. They have played a critical role in disease modeling, drug discovery, and cell replacement therapy, and have contributed to the evolution of disciplines such as cell biology, pathophysiology of diseases, and regenerative medicine. Organoids, the stem cell-derived 3D culture systems that mimic the structure and function of organs

Indexed as

3DCOVID-19disease modelIPSCorganoid

Identifiers

PMID37305682
PMCPMC10250752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.